GeneOne Life Science, Inc. (KRX:011000)

GeneOne Life Science Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 19, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	87,075	168,840	222,271	553,651	1,250,928	961,062
Market Cap Growth	-47.05%	-24.04%	-59.85%	-55.74%	30.16%	1733.31%
Enterprise Value	114,753	188,532	219,584	509,945	1,241,186	881,347
Last Close Price	1022.00	2115.00	2840.00	7140.00	16200.00	13850.76
PS Ratio	2.82	4.73	5.53	11.36	32.32	23.16
PB Ratio	1.57	1.97	1.99	3.05	6.06	9.76
P/TBV Ratio	1.58	1.98	2.00	3.06	6.08	9.82
EV/Sales Ratio	3.71	5.28	5.46	10.47	32.07	21.24
Debt / Equity Ratio	0.55	0.32	0.15	0.11	0.09	0.18
Net Debt / Equity Ratio	0.50	0.30	0.06	-0.14	-0.43	-0.74
Net Debt / EBITDA Ratio	-1.23	-1.01	-0.20	0.75	3.89	5.01
Net Debt / FCF Ratio	-1.62	-1.31	-0.26	0.37	1.02	2.27
Asset Turnover	0.23	0.24	0.22	0.21	0.20	0.44
Inventory Turnover	2.76	2.97	3.23	3.10	3.17	3.55
Quick Ratio	0.14	0.24	0.77	1.66	3.36	2.68
Current Ratio	0.50	0.67	1.51	2.16	3.87	2.96
Return on Equity (ROE)	-71.52%	-49.25%	-53.09%	-19.67%	-10.42%	-30.43%
Return on Assets (ROA)	-19.32%	-17.79%	-16.17%	-10.61%	-8.88%	-12.34%
Return on Capital Employed (ROCE)	-52.60%	-39.50%	-37.70%	-21.30%	-12.70%	-18.60%
Earnings Yield	-58.99%	-28.75%	-34.99%	-6.89%	-1.27%	-1.94%
FCF Yield	-19.66%	-11.46%	-12.30%	-12.54%	-6.98%	-3.34%
Buyback Yield / Dilution	-3.63%	-2.20%	-0.34%	-4.37%	-22.98%	-88.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.